← Browse by Condition
Medical Condition

kmt2ar

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06001788 Phase 1
Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Enrollment
171 pts
Location
United States, Italy...
Sponsor
Kura Oncology, Inc.
View Trial →